GE HealthCare (GEHC) Imaging CEO reports 7,885-share award vesting

Rhea-AI Filing Summary

GE HealthCare Technologies executive Roland Rott, CEO of Imaging, reported equity award activity in company stock. On February 12, 2026, he acquired 7,885 shares of common stock at $0 per share from the vesting of previously granted performance stock units after performance goals were certified. On the same date, 3,943 shares were disposed of at $79.2 per share to cover tax withholding tied to that vesting, a non-open-market transaction. After these entries, he directly owned 32,506 shares of GE HealthCare common stock.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Rott Roland

Role CEO, Imaging

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.01 per share	7,885	$0.00	--
Tax Withholding	Common Stock, par value $0.01 per share	3,943	$79.20	$312K

Holdings After Transaction: Common Stock, par value $0.01 per share — 36,449 shares (Direct)

Footnotes (1)

1. Performance stock units ("PSUs") granted on March 1, 2023, by GE HealthCare Technologies Inc. ("GE HealthCare"). Each PSU represented the right to receive one share of GE HealthCare common stock. The applicable performance criteria were satisfied and certified by GE HealthCare's Talent, Culture, and Compensation Committee and the PSUs vested on February 12, 2026. Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of PSUs.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rott Roland

(Last) (First) (Middle)

500 W. MONROE STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO, Imaging

3. Date of Earliest Transaction (Month/Day/Year)
02/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	02/12/2026		A		7,885(1)	A	$0	36,449	D
Common Stock, par value $0.01 per share	02/12/2026		F		3,943(2)	D	$79.2	32,506	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Performance stock units ("PSUs") granted on March 1, 2023, by GE HealthCare Technologies Inc. ("GE HealthCare"). Each PSU represented the right to receive one share of GE HealthCare common stock. The applicable performance criteria were satisfied and certified by GE HealthCare's Talent, Culture, and Compensation Committee and the PSUs vested on February 12, 2026.

2. Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of PSUs.

Remarks:

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did GEHC executive Roland Rott report?

Roland Rott reported vesting of equity awards, not an open-market trade. He received 7,885 GE HealthCare common shares from performance stock units and had 3,943 shares withheld to cover related taxes, leaving him with 32,506 directly owned shares after the transactions.

Was Roland Rott buying or selling GEHC stock in this Form 4 filing?

Roland Rott was not buying or selling on the open market. He acquired 7,885 GE HealthCare shares through the vesting of performance stock units and 3,943 shares were disposed of solely to satisfy tax withholding obligations triggered by that vesting event.

How many GEHC shares does Roland Rott own after the reported transactions?

After the reported equity award vesting and tax withholding, Roland Rott directly owns 32,506 GE HealthCare common shares. This figure reflects the 7,885 shares acquired from performance stock units minus 3,943 shares withheld to cover taxes on the vesting.

What triggered the 7,885-share award to GEHC executive Roland Rott?

The 7,885-share award came from performance stock units granted on March 1, 2023. These units converted into GE HealthCare common shares after the company’s Talent, Culture, and Compensation Committee certified that the applicable performance criteria were satisfied on February 12, 2026.

Why were 3,943 GEHC shares disposed of in Roland Rott’s Form 4?

The 3,943 GE HealthCare shares were withheld to cover tax obligations arising from the vesting of performance stock units. This disposition, reported with transaction code “F,” represents tax-withholding, not a discretionary market sale by the executive.

What is the role of Roland Rott at GE HealthCare Technologies Inc. (GEHC)?

Roland Rott serves as an officer of GE HealthCare Technologies Inc. with the title “CEO, Imaging.” The reported Form 4 transactions relate to his compensation in the form of company equity, including performance stock units that vested into common shares.